NEW YORK--(BUSINESS WIRE)--Tyme, Inc. (OTC QB: TYMI), a research and development company focused on developing drug candidates for the treatment of cancer, has appointed Giuseppe Del Priore, MD, MPH to serve on its Medical Advisory Board. Dr. Del Priore, a renowned gynecologic oncologist, researcher and teacher, is the National Director of Gynecologic Oncology and Southeastern Regional Director at Cancer Treatment Centers of America.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
